These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7325755)

  • 1. The influence of physostigmine on sympathetic outflow and haemodynamics by an action upon the pontomedullary region of the cat.
    de Wildt DJ; Porsius AJ
    Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):40-51. PubMed ID: 7325755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central cardiovascular effects of physostigmine in the cat; possible cholinergic aspects of blood pressure regulation.
    de Wildt DJ; Porsius AJ
    Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):22-39. PubMed ID: 6119963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central cardiovascular effects of physostigmine in anesthetized cats.
    Hara Y; Ally A; Murayama S
    Neuropharmacology; 1992 Sep; 31(9):923-8. PubMed ID: 1436399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digoxin toxicity: primary sites of drug action on the sympathetic nervous system.
    Weaver LC; Akera T; Brody TM
    J Pharmacol Exp Ther; 1976 Apr; 197(1):1-9. PubMed ID: 1263123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing responses in sympathetic nerve activity induced by central injections of ouabain.
    Weaver LC; Akera T; Brody TM
    J Pharmacol Exp Ther; 1975 Oct; 195(1):114-25. PubMed ID: 1102662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central effects of paraoxon on haemodynamics in the cat.
    de Neef JH; Porsius AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Sep; 317(2):168-72. PubMed ID: 7300920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of central administration of cholinomimetics in anesthetized cats.
    Ally A; Hara Y; Murayama S
    Neuropharmacology; 1993 Feb; 32(2):185-93. PubMed ID: 7680786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological actions of the antihypertensive agent N-amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride (BS 100-141).
    Scholtysik G; Lauener H; Eichenberger E; Bürki H; Salzmann R; Müller-Schweinitzer E; Waite R
    Arzneimittelforschung; 1975 Oct; 25(10):1483-91. PubMed ID: 1243025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Sympathetic nerve activity after noradrenaline depletion and its alteration by clonidine.
    Haeusler G
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R29. PubMed ID: 4276555
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of cardio- and hemodynamic reactions to administration of GABA into the neuronal structures of the ventrolateral area of the medulla oblongata of cats].
    Shapoval LN; Pobegaĭlo LS; Sagach VF
    Fiziol Zh (1978); 1991; 37(1):18-24. PubMed ID: 2055305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Action of delta 9 tetrahydrocannabinol on the central cardiovascular regulation : mechanism and localization].
    Daskalopoulos N; Schmitt H; Laubie M
    Encephale; 1975; 1(2):121-32. PubMed ID: 240671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The local effect of pH changes in the cerebrospinal fluid on the ventrolateral areas of medulla oblongata and on the spinal cord surface on the activity of cardiac and vertebral sympathetic nerves.
    Szulczyk P; Trzebski A
    Acta Physiol Pol; 1976; 27(1):9-17. PubMed ID: 5847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathetic nervous system mediated cardiovascular effects of cocaine are primarily due to a peripheral site of action of the drug.
    Gillis RA; Hernandez YM; Erzouki HK; Raczkowski VF; Mandal AK; Kuhn FE; Dretchen KL
    Drug Alcohol Depend; 1995 Mar; 37(3):217-30. PubMed ID: 7796716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular control by cholinergic mechanisms in the rostral ventrolateral medulla.
    Willette RN; Punnen S; Krieger AJ; Sapru HN
    J Pharmacol Exp Ther; 1984 Nov; 231(2):457-63. PubMed ID: 6149311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of sympathetic nervous system in the action of dopamine and dobutamine on the function of circulatory system.
    Krawczak J; Beutler A; Kozłowska T; Olejnik A
    Pol J Pharmacol Pharm; 1989; 41(6):639-48. PubMed ID: 2485908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for an alpha-1 receptor-mediated central sympathoinhibitory action of ketanserin.
    McCall RB; Schuette MR
    J Pharmacol Exp Ther; 1984 Mar; 228(3):704-10. PubMed ID: 6323678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sympathetic efferent activity in various nerves and regional blood flow in controlled bradycardia].
    Pokrovskiĭ VM; Khakon SM; Kade AKh
    Fiziol Zh SSSR Im I M Sechenova; 1988 May; 74(5):706-13. PubMed ID: 2843401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the cardiovascular effects of co-derocrine (Hydergine).
    Clark BJ; Bucher T; Waite R
    J Pharmacol; 1985; 16 Suppl 3():101-11. PubMed ID: 2869189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of L-DOPA on blood pressure and sympathetic nerve activity after decarboxylase inhibition in cats.
    Watanabe AM; Judy WV; Cardon PV
    J Pharmacol Exp Ther; 1974 Jan; 188(1):107-13. PubMed ID: 4809262
    [No Abstract]   [Full Text] [Related]  

  • 20. Rostral ventromedial medulla and the control of cutaneous vasoconstrictor activity following i.c.v. prostaglandin E(1).
    Korsak A; Gilbey MP
    Neuroscience; 2004; 124(3):709-17. PubMed ID: 14980740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.